Using isogenic cells lines we could demonstrate that the introduction of an oncogenic mutation in KRAS rendered NCI-H838 cancer cells more capable of recovering from IR-induced mitochondrial shutdown and this was associated with an improved ability to remove IR-induced DNA damage foci. The gene discussed is KRAS; the disease is cancer.